Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 475

1.

Better Sepsis Management Rather Than Fluoroquinolone Prophylaxis for Patients With Cancer-Related Immunosuppression.

Slavin MA, Worth LJ, Seymour JF, Thursky KA.

J Clin Oncol. 2019 Mar 7:JCO1801474. doi: 10.1200/JCO.18.01474. [Epub ahead of print] No abstract available.

PMID:
30844318
2.

Patients' and Providers' Views on Causes and Consequences of Healthcare Fragmentation in the Ambulatory Setting: a Qualitative Study.

Kern LM, Safford MM, Slavin MJ, Makovkina E, Fudl A, Carrillo JE, Abramson EL.

J Gen Intern Med. 2019 Feb 19. doi: 10.1007/s11606-019-04859-1. [Epub ahead of print]

PMID:
30783883
3.

Impact of a hospital-wide sepsis pathway on improved quality of care and clinical outcomes in surgical patients at a comprehensive cancer centre.

Hiong A, Thursky KA, Venn G, Teh BW, Haeusler GM, Crane M, Slavin MA, Worth LJ.

Eur J Cancer Care (Engl). 2019 Feb 13:e13018. doi: 10.1111/ecc.13018. [Epub ahead of print]

PMID:
30761632
4.

The Cerebral Palsy Profile of Health and Function: Upper-Extremity Domain's Sensitivity to Change Following Musculoskeletal Surgery.

Grampurohit N, Slavin M, Ni P, Kozin S, Jette A, Mulcahey M.

J Hand Surg Am. 2019 Feb 4. pii: S0363-5023(18)30485-4. doi: 10.1016/j.jhsa.2018.12.007. [Epub ahead of print]

PMID:
30733101
5.

Utilizing genomic analyses to investigate the first outbreak of vanA vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility.

Douglas AP, Marshall C, Baines SL, Ritchie D, Szer J, Madigan V, Chan HT, Ballard SA, Howden BP, Buising K, Slavin MA.

J Med Microbiol. 2019 Mar;68(3):303-308. doi: 10.1099/jmm.0.000916. Epub 2019 Jan 21.

PMID:
30663951
6.

The contemporary management and clinical outcomes of mucormycosis: a systematic review and meta-analysis of case reports.

Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Chen SC, Kong DCM.

Int J Antimicrob Agents. 2019 Jan 9. pii: S0924-8579(19)30002-0. doi: 10.1016/j.ijantimicag.2019.01.002. [Epub ahead of print]

PMID:
30639526
7.

High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia.

Teh BW, Chui W, Handunnetti S, Tam C, Worth LJ, Thursky KA, Slavin MA.

Leuk Lymphoma. 2019 Jan 11:1-4. doi: 10.1080/10428194.2018.1543884. [Epub ahead of print] No abstract available.

PMID:
30632838
8.

Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®.

Seidel D, Meißner A, Lackner M, Piepenbrock E, Salmanton-García J, Stecher M, Mellinghoff S, Hamprecht A, Durán Graeff L, Köhler P, Cheng MP, Denis J, Chedotal I, Chander J, Pakstis DL, Los-Arcos I, Slavin M, Montagna MT, Caggiano G, Mares M, Trauth J, Aurbach U, Vehreschild MJGT, Vehreschild JJ, Duarte RF, Herbrecht R, Wisplinghoff H, Cornely OA.

Crit Rev Microbiol. 2019 Jan 10:1-21. doi: 10.1080/1040841X.2018.1514366. [Epub ahead of print] Erratum in: Crit Rev Microbiol. 2019 Feb 18;:1.

PMID:
30628529
9.

Whole Genome Sequencing of Australian Candida glabrata Isolates Reveals Genetic Diversity and Novel Sequence Types.

Biswas C, Marcelino VR, Van Hal S, Halliday C, Martinez E, Wang Q, Kidd S, Kennedy K, Marriott D, Morrissey CO, Arthur I, Weeks K, Slavin MA, Sorrell TC, Sintchenko V, Meyer W, Chen SC.

Front Microbiol. 2018 Dec 3;9:2946. doi: 10.3389/fmicb.2018.02946. eCollection 2018.

10.

The Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study.

Trubiano JA, Smibert O, Douglas A, Devchand M, Lambros B, Holmes NE, Chua KY, Phillips EJ, Slavin MA.

Open Forum Infect Dis. 2018 Nov 17;5(12):ofy306. doi: 10.1093/ofid/ofy306. eCollection 2018 Dec.

11.

Determining a transitional scoring link between PROMIS® pediatric and adult physical health measures.

Tulsky DS, Kisala PA, Boulton AJ, Jette AM, Thissen D, Ni P, DeWalt DA, Huang IC, Liu Y, Mulcahey MJ, Slavin M, Magnus B, Crump H, Hanks R, Charlifue S, Reeve BB.

Qual Life Res. 2018 Dec 11. doi: 10.1007/s11136-018-2073-3. [Epub ahead of print]

PMID:
30539361
12.

Antifungal stewardship: developments in the field.

Urbancic KF, Thursky K, Kong DCM, Johnson PDR, Slavin MA.

Curr Opin Infect Dis. 2018 Dec;31(6):490-498. doi: 10.1097/QCO.0000000000000497.

PMID:
30299362
13.

Invasive fungal disease and cytomegalovirus infection: is there an association?

Yong MK, Slavin MA, Kontoyiannis DP.

Curr Opin Infect Dis. 2018 Dec;31(6):481-489. doi: 10.1097/QCO.0000000000000502.

PMID:
30299361
14.

The safety of antibiotic skin testing in severe T-cell-mediated hypersensitivity of immunocompetent and immunocompromised hosts.

Trubiano JA, Douglas AP, Goh M, Slavin MA, Phillips EJ.

J Allergy Clin Immunol Pract. 2018 Sep 26. pii: S2213-2198(18)30590-7. doi: 10.1016/j.jaip.2018.09.014. [Epub ahead of print] No abstract available.

PMID:
30266590
15.

Access, knowledge and experience with FDG-PET/CT in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologists.

Douglas AP, Thursky KA, Worth LJ, Harrison SJ, Hicks RJ, Slavin MA.

Intern Med J. 2018 Sep 19. doi: 10.1111/imj.14117. [Epub ahead of print]

PMID:
30230669
16.

The Role of Impulsivity and Expectancies in Predicting Marijuana Use: An Application of the Acquired Preparedness Model.

Luba R, Earleywine M, Farmer S, Slavin M, Mian M, Altman B.

J Psychoactive Drugs. 2018 Nov-Dec;50(5):411-419. doi: 10.1080/02791072.2018.1511877. Epub 2018 Sep 5.

PMID:
30183528
17.

Contextualizing disability: a cross-sectional analysis of the association between the built environment and functioning among people living with spinal cord injury in the United States.

Botticello AL, Tulsky D, Heinemann A, Charlifue S, Kalpakjian C, Slavin M, Byrne R, Rohrbach T.

Spinal Cord. 2019 Feb;57(2):100-109. doi: 10.1038/s41393-018-0186-8. Epub 2018 Aug 14.

18.

European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.

Maertens JA, Girmenia C, Brüggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN) .

J Antimicrob Chemother. 2018 Dec 1;73(12):3221-3230. doi: 10.1093/jac/dky286.

PMID:
30085172
19.

Antibiotic allergy testing improves antibiotic appropriateness in patients with cancer.

Trubiano JA, Grayson ML, Phillips EJ, Stewardson AJ, Thursky KA, Slavin MA.

J Antimicrob Chemother. 2018 Nov 1;73(11):3209-3211. doi: 10.1093/jac/dky307. No abstract available.

PMID:
30060208
20.

The effect of bariatric surgery on hypothyroidism: Sleeve gastrectomy versus gastric bypass.

Rudnicki Y, Slavin M, Keidar A, Kent I, Berkovich L, Tiomkin V, Inbar R, Avital S.

Surg Obes Relat Dis. 2018 Sep;14(9):1297-1303. doi: 10.1016/j.soard.2018.06.008. Epub 2018 Jun 15.

PMID:
30049595
21.

The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports.

Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, Chen SC.

Clin Microbiol Infect. 2019 Jan;25(1):26-34. doi: 10.1016/j.cmi.2018.07.011. Epub 2018 Jul 21. Review.

PMID:
30036666
22.

Implementation of a whole of hospital sepsis clinical pathway in a cancer hospital: impact on sepsis management, outcomes and costs.

Thursky K, Lingaratnam S, Jayarajan J, Haeusler GM, Teh B, Tew M, Venn G, Hiong A, Brown C, Leung V, Worth LJ, Dalziel K, Slavin MA.

BMJ Open Qual. 2018 Jul 6;7(3):e000355. doi: 10.1136/bmjoq-2018-000355. eCollection 2018.

23.

Social Interactions and Social Activities After Burn Injury: A Life Impact Burn Recovery Evaluation (LIBRE) Study.

Ohrtman EA, Shapiro GD, Simko LC, Dore E, Slavin MD, Saret C, Amaya F, Lomelin-Gascon J, Ni P, Acton A, Marino M, Kazis LE, Ryan CM, Schneider JC.

J Burn Care Res. 2018 Oct 23;39(6):1022-1028. doi: 10.1093/jbcr/iry038.

PMID:
30016442
24.

How antibiotic allergy labels may be harming our most vulnerable patients.

Trubiano JA, Grayson ML, Thursky KA, Phillips EJ, Slavin MA.

Med J Aust. 2018 Jun 18;208(11):469-470. No abstract available.

25.

FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging.

Douglas AP, Thursky KA, Worth LJ, Drummond E, Hogg A, Hicks RJ, Slavin MA.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):166-173. doi: 10.1007/s00259-018-4062-8. Epub 2018 Jun 7.

PMID:
29882160
26.

A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases.

Revankar SG, Baddley JW, Chen SC, Kauffman CA, Slavin M, Vazquez JA, Seas C, Morris MI, Nguyen MH, Shoham S, Thompson GR 3rd, Alexander BD, Simkins J, Ostrosky-Zeichner L, Mullane K, Alangaden G, Andes DR, Cornely OA, Wahlers K, Lockhart SR, Pappas PG.

Open Forum Infect Dis. 2017 Sep 26;4(4):ofx200. doi: 10.1093/ofid/ofx200. eCollection 2017 Fall.

27.

Cannabis in End-of-Life Care: Examining Attitudes and Practices of Palliative Care Providers.

Luba R, Earleywine M, Farmer S, Slavin M.

J Psychoactive Drugs. 2018 Sep-Oct;50(4):348-354. doi: 10.1080/02791072.2018.1462543. Epub 2018 May 1.

PMID:
29714640
28.

Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies.

Teh BW, Tam CS, Handunnetti S, Worth LJ, Slavin MA.

Blood Rev. 2018 Nov;32(6):499-507. doi: 10.1016/j.blre.2018.04.007. Epub 2018 Apr 23. Review.

PMID:
29709246
29.

Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practice.

Haeusler GM, Slavin MA, Bryant PA, Babl FE, Mechinaud F, Thursky KA.

J Paediatr Child Health. 2018 Jul;54(7):761-769. doi: 10.1111/jpc.13899. Epub 2018 Apr 14.

PMID:
29655245
30.

Sensitivity of the SCI-FI/AT in Individuals With Traumatic Spinal Cord Injury.

Keeney T, Slavin M, Kisala P, Ni P, Heinemann AW, Charlifue S, Fyffe DC, Marino RJ, Morse LR, Worobey LA, Tate D, Rosenblum D, Zafonte R, Tulsky D, Jette AM.

Arch Phys Med Rehabil. 2018 Sep;99(9):1783-1788. doi: 10.1016/j.apmr.2018.02.014. Epub 2018 Mar 31.

PMID:
29608900
31.

Structural Analysis of Protein Complexes by Cross-Linking and Mass Spectrometry.

Slavin M, Kalisman N.

Methods Mol Biol. 2018;1764:173-183. doi: 10.1007/978-1-4939-7759-8_11.

PMID:
29605915
32.

Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular Testing.

Sim SA, Leung VKY, Ritchie D, Slavin MA, Sullivan SG, Teh BW.

Biol Blood Marrow Transplant. 2018 Jul;24(7):1490-1496. doi: 10.1016/j.bbmt.2018.03.004. Epub 2018 Mar 9.

PMID:
29530766
33.

Factors contributing to declination of annual influenza vaccination by healthcare workers caring for cancer patients: An Australian experience.

Surtees TC, Teh BW, Slavin MA, Worth LJ.

Vaccine. 2018 Mar 27;36(14):1804-1807. doi: 10.1016/j.vaccine.2018.02.098. Epub 2018 Mar 2.

PMID:
29503114
34.

In vitro activity of the novel antifungal compound F901318 against Australian Scedosporium and Lomentospora fungi.

Biswas C, Law D, Birch M, Halliday C, Sorrell TC, Rex J, Slavin M, Chen SC.

Med Mycol. 2018 Nov 1;56(8):1050-1054. doi: 10.1093/mmy/myx161.

PMID:
29370408
35.

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance.

Biswas C, Chen SC, Halliday C, Martinez E, Rockett RJ, Wang Q, Timms VJ, Dhakal R, Sadsad R, Kennedy KJ, Playford G, Marriott DJ, Slavin MA, Sorrell TC, Sintchenko V.

J Vis Exp. 2017 Dec 28;(130). doi: 10.3791/56714.

PMID:
29364212
36.

Detecting functional change in response to exercise in knee osteoarthritis: a comparison of two computerized adaptive tests.

Chang FH, Jette AM, Slavin MD, Baker K, Ni P, Keysor JJ.

BMC Musculoskelet Disord. 2018 Jan 23;19(1):29. doi: 10.1186/s12891-018-1942-9.

37.

Single-centre study of therapeutic drug monitoring of posaconazole in lung transplant recipients: factors affecting trough plasma concentrations.

Jeong W, Snell GI, Levvey BJ, Westall GP, Morrissey CO, Wolfe R, Ivulich S, Neoh CF, Slavin MA, Kong DCM.

J Antimicrob Chemother. 2018 Mar 1;73(3):748-756. doi: 10.1093/jac/dkx440.

PMID:
29211913
38.

Low T-Cell Responses to Mitogen Stimulation Predicts Poor Survival in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.

Yong MK, Cameron PU, Slavin MA, Cheng AC, Morrissey CO, Bergin K, Spencer A, Ritchie D, Lewin SR.

Front Immunol. 2017 Nov 9;8:1506. doi: 10.3389/fimmu.2017.01506. eCollection 2017.

39.

The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions.

Trubiano JA, Strautins K, Redwood AJ, Pavlos R, Konvinse KC, Aung AK, Slavin MA, Thursky KA, Grayson ML, Phillips EJ.

J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1287-1296.e1. doi: 10.1016/j.jaip.2017.09.004. Epub 2017 Oct 31.

40.
41.

Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling.

Teh BW, Harrison SJ, Allison CC, Slavin MA, Spelman T, Worth LJ, Thursky KA, Ritchie D, Pellegrini M.

Front Immunol. 2017 Oct 5;8:1247. doi: 10.3389/fimmu.2017.01247. eCollection 2017.

42.

Safety and cost benefit of an ambulatory program for patients with low-risk neutropenic fever at an Australian centre.

Teh BW, Brown C, Joyce T, Worth LJ, Slavin MA, Thursky KA.

Support Care Cancer. 2018 Mar;26(3):997-1003. doi: 10.1007/s00520-017-3921-3. Epub 2017 Oct 10.

PMID:
29018966
43.

Intravenous opioid drug abuse as an independent risk factor for supraglottic squamous cell carcinoma-A case-control study.

Shoffel-Havakuk H, Cohen O, Slavin M, Haimovich Y, Halperin D, Lahav Y.

Clin Otolaryngol. 2018 Apr;43(2):456-462. doi: 10.1111/coa.12990. Epub 2017 Oct 9.

PMID:
28950046
44.

What, where and why: exploring fluorodeoxyglucose-PET's ability to localise and differentiate infection from cancer.

Douglas A, Lau E, Thursky K, Slavin M.

Curr Opin Infect Dis. 2017 Dec;30(6):552-564. doi: 10.1097/QCO.0000000000000405. Review.

PMID:
28922285
45.

Impact of a dedicated post-transplant vaccination service at an Australian cancer centre.

Teh BW, Joyce T, Slavin MA, Thursky KA, Worth LJ.

Bone Marrow Transplant. 2017 Dec;52(12):1681-1683. doi: 10.1038/bmt.2017.195. Epub 2017 Sep 18. No abstract available.

PMID:
28920950
46.

External Validation of Six Pediatric Fever and Neutropenia Clinical Decision Rules.

Haeusler GM, Thursky KA, Slavin MA, Mechinaud F, Babl FE, Bryant P, De Abreu Lourenco R, Phillips R.

Pediatr Infect Dis J. 2018 Apr;37(4):329-335. doi: 10.1097/INF.0000000000001777.

PMID:
28877157
47.

The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

Trubiano JA, Stone CA, Grayson ML, Urbancic K, Slavin MA, Thursky KA, Phillips EJ.

J Allergy Clin Immunol Pract. 2017 Nov - Dec;5(6):1532-1542. doi: 10.1016/j.jaip.2017.06.017. Epub 2017 Aug 23. Review. Erratum in: J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):323.

48.

Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study in the Current Era of Viral Load Monitoring.

Yong MK, Ananda-Rajah M, Cameron PU, Morrissey CO, Spencer A, Ritchie D, Cheng AC, Lewin SR, Slavin M.

Biol Blood Marrow Transplant. 2017 Nov;23(11):1961-1967. doi: 10.1016/j.bbmt.2017.07.025. Epub 2017 Aug 7.

49.

Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer.

Colombo AL, de Almeida Júnior JN, Slavin MA, Chen SC, Sorrell TC.

Lancet Infect Dis. 2017 Nov;17(11):e344-e356. doi: 10.1016/S1473-3099(17)30304-3. Epub 2017 Jul 31. Review.

PMID:
28774702
50.

Placebo Effects of Edible Cannabis: Reported Intoxication Effects at a 30-Minute Delay.

Loflin MJE, Earleywine M, Farmer S, Slavin M, Luba R, Bonn-Miller M.

J Psychoactive Drugs. 2017 Nov-Dec;49(5):393-397. doi: 10.1080/02791072.2017.1354409. Epub 2017 Aug 3.

PMID:
28771093

Supplemental Content

Loading ...
Support Center